Table of Contents Author Guidelines Submit a Manuscript
Journal of Spectroscopy
Volume 2015, Article ID 681320, 11 pages
http://dx.doi.org/10.1155/2015/681320
Research Article

Micellar Enhanced Three-Dimensional Excitation-Emission Matrix Fluorescence for Rapid Determination of Antihypertensives in Human Plasma with Aid of Second-Order Calibration Methods

1Third Class Laboratory about Ethno-Medicine of State Administration of Traditional Chinese Medicine, College of Pharmacy, South-Central University for Nationalities, Wuhan 430074, China
2State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310032, China

Received 22 May 2015; Accepted 5 August 2015

Academic Editor: Feride Severcan

Copyright © 2015 Hai-Yan Fu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Julius, S. E. Kjeldsen, M. Weber et al., “Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial,” The Lancet, vol. 363, no. 9426, pp. 2022–2031, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. S. Sever, B. Dahlöf, N. R. Poulter et al., “Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial,” The Lancet, vol. 361, no. 9364, pp. 1149–1158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Gueyffier, C. Bulpitt, J.-P. Boissel et al., “Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials,” The Lancet, vol. 353, no. 9155, pp. 793–796, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Materson, “Variability in response to antihypertensive drugs,” The American Journal of Medicine, vol. 120, no. 4, pp. S10–S20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. Shafiq, D. V. Menon, and R. G. Victor, “Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug,” American Journal of Medicine, vol. 121, no. 4, pp. 265–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Q.-Z. Li, Q. Deng, J.-Q. Li, G.-H. Yi, and S.-P. Zhao, “Valsartan reduces interleukin-1β secretion by peripheral blood mononuclear cells in patients with essential hypertension,” Clinica Chimica Acta, vol. 355, no. 1-2, pp. 131–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Li, Q. Wang, Q. Xu et al., “Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor,” Life Sciences, vol. 110, no. 2, pp. 70–76, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Potamitis, P. Chatzigeorgiou, E. Siapi et al., “Interactions of the AT1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1808, no. 6, pp. 1753–1763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. I. Sohn, N. J. Lee, A. Chung et al., “Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking,” Biochemical and Biophysical Research Communications, vol. 439, no. 4, pp. 464–470, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Fasani, A. Albini, and S. Gemme, “Mechanism of the photochemical degradation of amlodipine,” International Journal of Pharmaceutics, vol. 352, no. 1-2, pp. 197–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Kim, M. Son, D. Lee et al., “Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study,” Clinical Therapeutics, vol. 35, no. 7, pp. 934–940, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Toma, C. S. Stancu, G. M. Sanda, and A. V. Sima, “Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL,” Biochemical and Biophysical Research Communications, vol. 411, no. 1, pp. 202–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. G. Gadepalli, P. Deme, M. Kuncha, and R. Sistla, “Simultaneous determination of amlodipine, valsartan and hydrochlorothiazide by LC-ESI-MS/MS and its application to pharmacokinetics in rats,” Journal of Pharmaceutical Analysis, vol. 4, no. 6, pp. 399–406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Koseki, H. Kawashita, H. Hara et al., “Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 5, pp. 1769–1774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. S. Selvan, K. V. Gowda, U. Mandal, W. D. S. Solomon, and T. K. Pal, “Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 858, no. 1-2, pp. 143–150, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Yan, W. Wang, L. Chen, and S. Chen, “Electrochemical behavior of valsartan and its determination in capsules,” Colloids and Surfaces B: Biointerfaces, vol. 67, no. 2, pp. 205–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Krishnaiah, A. R. Reddy, R. Kumar, and K. Mukkanti, “Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms,” Journal of Pharmaceutical and Biomedical Analysis, vol. 53, no. 3, pp. 483–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Shaalan, T. S. Belal, F. A. El Yazbi, and S. M. Elonsy, “Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets,” Arabian Journal of Chemistry, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. S. Haug, C. Thomsen, V. H. Liane, and G. Becher, “Comparison of GC and LC determinations of hexabromocyclododecane in biological samples—results from two interlaboratory comparison studies,” Chemosphere, vol. 71, no. 6, pp. 1087–1092, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. N. Goyal and S. Bishnoi, “Voltammetric determination of amlodipine besylate in human urine and pharmaceuticals,” Bioelectrochemistry, vol. 79, no. 2, pp. 234–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Norouzi, V. K. Gupta, B. Larijani, S. Rasoolipour, F. Faridbod, and M. R. Ganjali, “Coulometric differential FFT admittance voltammetry determination of Amlodipine in pharmaceutical formulation by nano-composite electrode,” Talanta, vol. 131, pp. 577–584, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. F. Valezi, E. H. Duarte, G. R. Mansano, L. H. Dall'Antonia, C. R. T. Tarley, and E. R. Sartori, “An improved method for simultaneous square-wave voltammetric determination of amlodipine and enalapril at multi-walled carbon nanotubes paste electrode based on effect of cationic surfactant,” Sensors and Actuators, B: Chemical, vol. 205, pp. 234–243, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Chang, J. Li, J. Li et al., “Simultaneous determination of amlodipine and bisoprolol in rat plasma by a liquid chromatography/tandem mass spectrometry method and its application in pharmacokinetic study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 71, pp. 104–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Shentu, L. Fu, H. Zhou et al., “Determination of amlodipine in human plasma using automated online solid-phase extraction HPLC-tandem mass spectrometry: application to a bioequivalence study of Chinese volunteers,” Journal of Pharmaceutical and Biomedical Analysis, vol. 70, pp. 614–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. M. Escandar, H. C. Goicoechea, A. Muñoz de la Peña, and A. C. Olivieri, “Second- and higher-order data generation and calibration: a tutorial,” Analytica Chimica Acta, vol. 806, pp. 8–26, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H.-L. Wu, Y. Li, and R.-Q. Yu, “Recent developments of chemical multiway calibration methodologies with second-order or higher-order advantages,” Journal of Chemometrics, vol. 28, no. 5, pp. 476–489, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. R. A. Harshman, “Foundations of the PARAFAC procedure: model and conditions for an ‘explanatory’ multi-mode factor analysis,” UCLA Working Papers in Phonetics, vol. 16, pp. 1–84, 1970. View at Google Scholar
  28. H.-L. Wu, M. Shibukawa, and K. Oguma, “An alternating trilinear decomposition algorithm with application to calibration of HPLC-DAD for simultaneous determination of overlapped chlorinated aromatic hydrocarbons,” Journal of Chemometrics, vol. 12, no. 1, pp. 1–26, 1998. View at Publisher · View at Google Scholar · View at Scopus